(Q33489427)

27 July 2017

1 reference

title

Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme (English)

1 reference

27 July 2017

1 reference

A D Wright

1

1 reference

27 July 2017

P M Dodson

series ordinal

2

1 reference

27 July 2017

publication date

24 July 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

24

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

1-6

1 reference

Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

Angiotensin and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

Renal and retinal effects of enalapril and losartan in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

7 January 2021

Overview of studies on metabolic and vascular regulatory changes in early diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

7 January 2021

Vascular endothelial growth factor is a critical stimulus for diabetic macular edema

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

7 January 2021

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.189

7 January 2021

Identifiers

DOI

10.1038/EYE.2009.189

1 reference

Dimensions Publication ID

27 July 2017

1040320551

0 references

1 reference